PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: PRHUB

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Cellworks Research India Ltd and Lifeline Hospitals Enter into Collaboration and Licensing Agreement in Oncology - Cellworks Research India Ltd, the R&D wing of California based company Cellworks Group Inc. and Lifeline Multi Speciality Hospitals have announced one year research collaboration in the area of oncology with emphasis on study of the role of Tumor Stem
Cellworks Research India Ltd and Lifeline Hospitals Enter into Collaboration and Licensing Agreement in Oncology

 

NewswireToday - /newswire/ - Shantinagar, Karnataka, India, 2008/03/24 - Cellworks Research India Ltd, the R&D wing of California based company Cellworks Group Inc. and Lifeline Multi Speciality Hospitals have announced one year research collaboration in the area of oncology with emphasis on study of the role of Tumor Stem.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This collaborative research will exploit the unique prowess of Cellworks technology iC-PHYS, a proprietary in silico platform, which provides a disease physiology aligned dynamic representation at the bio-molecular abstraction level. The technology platform iC-PHYS™ Tumor Cell, is MDR Aware and enables virtual prototyping to incorporate drug-resistance factors in the drug discovery process. This prototyping minimizes efficacy issues due to drug resistance that may show up at clinical trials stages. Also the various cancer phenotypes are comprehensively included in this technology platform.

According to Dr. J S RajKumar – Founder and Chairman, Lifeline Hospitals; “Lifeline Hospitals is pioneering Clinical Trials using Cell based therapies. One significant need for us to offer differentiated solutions in the area of oncology is to gain deep knowledge of the sequential cellular level events which take place during cancer progression. We are partnering with Cellworks Group Inc. to better understand the details of the cellular bio-chemical pathways and proteins involved in the differentiation process. Cellworks team with its in-depth expertise in Cellular modeling and rich library of in silico based proprietary platforms has been identified to be the optimal partner in this exciting and emergent area. Lifeline is proud to be associated with a pioneering company like Cellworks.”

“I am very excited with the potential of this partnership” said Taher Abbasi, CEO of Cellworks. “Molecular bio-markers identification is fundamental for understanding cancer progression and for adaptive treatment solutions for maximum efficacy and minimized drug resistance. Transparency into all cancer phenotypes and intermediate nodes simultaneously through the iC-PHYS™ platform and correlation with the clinical data points will expand opportunities for personalized medicine in cancer treatment”.

According to Dr. Anand Kumar, Chairman Board of Cellworks Research India Ltd – "It gives me great pleasure to see two best in class companies coming together through this engagement model. It is very exciting to observe the extensibility of the Cellworks’ solutions to a very new facet of oncology research".

About Lifeline Multi Speciality Hospital

Lifeline Multi Speciality Hospital is a landmark tertiary care health destination managed by Lifeline Group of Hospitals. First of its kind in South East Chennai, the 225 bedded hospital has the state-of-the-art technology over virtually all specialities. The technology advantage is complemented by the man power excellence providing sophisticated and specialised medical care at affordable cost. Lifeline Multi Speciality Hospital caters to the medical requirements of a very large cross section of people.

About Cellworks

Cellworks Group, Inc. is a California Incorporated company with its R&D facility (Cellworks Research India Ltd) based in Bangalore, India. Cellworks adopts a multi-disciplinary and analytical approach to solve biological problems and is part of a new technology wave that will change people’s perception of the diagnosis and treatment of human disease.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PRHUB

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Cellworks Research India Ltd and Lifeline Hospitals Enter into Collaboration and Licensing Agreement in Oncology

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Tania - PRHUB.com 
+91 80 22483007 tania[.]prhub.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PRHUB securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PRHUB / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

ZOLL Canada Wins Tender to Equip Province of Québec Paramedic Services with ZOLL X Series Monitor/Defibrillators
Top Speakers, Brands Commit to SCBIO 2017 - SC Governor McMaster to Keynote Life Sciences Conference
Frost & Sullivan Recognizes Acelity as a Leader in the Field with its New V.A.C.ULTA™ 4 Therapy System and V.A.C. VERAFLO CLEANSE CHOICE™ Dressing
Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)